FDA updates cybersecurity guidance for medical device makers
The Food and Drug Administration Sept. 26 finalized guidance updating the cybersecurity information device makers should submit to its Center for Devices and Radiological Health or Center for Biologics Evaluation and Research for premarket review of devices that have cybersecurity considerations. The recommendations are intended to help manufacturers meet their obligations under section 524B of the Federal Food, Drug, and Cosmetic Act, enacted in December 2022 as part of the Consolidated Appropriations Act of 2023, which defines “cyber device” as one that includes a device or software that can connect to the internet and be vulnerable to cybersecurity threats.
Related News Articles
Headline
The AHA is advising hospitals and health systems to be alert for potential scam calls where actors are impersonating Drug Enforcement Agency agents. An AHA…
Headline
The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of vulnerabilities found in the Contec…
Headline
The AHA yesterday released an advisory alerting members that the association and the Health Information Sharing and Analysis Center have identified attempted…
Headline
The ransomware attack last year against UnitedHealth Group subsidiary Change Healthcare exposed data of more than 190 million people — up from previous reports…
Headline
The Cybersecurity and Infrastructure Security Agency and FBI Jan. 22 released an advisory explaining how cyberthreat actors “chained” vulnerabilities —…
Headline
A guide published Jan. 13 by the Cybersecurity and Infrastructure Security Agency, National Security Agency, FBI, Environmental Protection Agency,…